ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
March 23, 2023
Person walking on directional sign
March 23, 2023
Categories
  • Editorials

Should I stay or should I go?

Many patients are unaware that stopping treatment during participation in a clinical trial does not automatically mean withdrawing from a clinical trial
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • New Trials

The ComboMATCH precision medicine initiative is getting set to evaluate several new anti-cancer drug combinations

Hospitals and cancer centers nationwide are opening ComboMATCH on a rolling basis over the next few months
Do you like it?
0 Read more
March 23, 2023
March 23, 2023
Categories
  • Ongoing Trials

Video: Advocates discuss the EA2185 research study for patients with pancreatic cysts

Watch cancer research advocates Lisa Beckendorf and Steven Merlin discuss the EA2185 study for patients with pancreatic cysts
Do you like it?
0 Read more
March 23, 2023
Doctor talking with older male patient
March 23, 2023
Categories
  • Ongoing Trials

Ongoing Trials: A closer look at ECOG-ACRIN’s myeloma studies

These two trials are exploring new treatment approaches for adults with multiple myeloma
Do you like it?
0 Read more
March 23, 2023
Research dictionary entry
March 23, 2023
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Winter 2023

Summaries of recently reported ECOG-ACRIN research results
Do you like it?
0 Read more

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}